GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medeon Biodesign 6499.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

73.00

+2.96%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Medeon Biodesign

Its shares trade on Taipei Exchange under the ticker 6499.TWO. It has been listed since 11 December 2014. In the fiscal year to 31 December 2025, it reported revenue of TWD 419.4m and a net loss of TWD 668.1m. At that date it held total assets of TWD 1.78bn and shareholders' equity of TWD 1.48bn.

Medeon Biodesign, Inc. engages in the development, manufacture, and sale of medical equipment. The company is headquartered in Taipei City, Taipei. The company went IPO on 2014-12-11. The firm's main products include medical apparatus and instruments used in laparoscopic minimally invasive surgeries and cardiac catheter-related minimally invasive surgeries. The firm distributes its products in domestic market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
11 Dec 2014

Leadership

Pay as last reported

  • Mr. Yue Teh JangChairman of the Board, General Manager, since 2016
  • Jingyi ChenChief Financial Officer
  • Yiru ChenDeputy General Manager-Operating
  • Yijing WuDeputy General Manager-Enterprise Development
  • Javin WangHead of Accounting
  • Mr. Jung-Chin LinDirector, since 2021
  • Zhixiong WuDirector
  • Jiaying MaIndependent Director
  • Fengxiang YangIndependent Director
  • Mr. Qihang YangIndependent Director
  • Mr. Jien-Wei YehIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Medeon Biodesign Inc develops medical equipment for minimally invasive surgeries.
  • The company manufactures instruments used in laparoscopic and cardiac procedures.
  • Medeon Biodesign Inc sells products in domestic and overseas markets.

Weaknesses

  • The company is headquartered in Taipei City, Taiwan.
  • Medeon Biodesign Inc went public on 11 December 2014.
  • The firm operates within the Health Care sector in Taiwan.

Opportunities

  • Medeon Biodesign Inc distributes its medical apparatus to overseas markets.
  • The company sells instruments for cardiac catheter-related minimally invasive surgeries.
  • Medeon Biodesign Inc engages in the development of medical equipment.

Threats

  • Medeon Biodesign Inc faces competition in the Health Care sector.
  • The company relies on the domestic market in Taiwan.
  • Medeon Biodesign Inc operates from Taipei City, Taiwan.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.